Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas

Clinical trial NCT01188785 · COMPLETED

Trial details

NCT number: NCT01188785
Sponsor: Silenseed Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Pancreatic Cancer

Start date: 2011-01-01
Primary completion: 2013-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.